Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dobutamine during one-lung ventilation
ChiCTR1900023085Phase 4Recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dobutamine in lung nodule (SPN) (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoint: Regional cerebral oxygen saturation. Started May 2019; status: recruiting.
02
Drugs
dobutamine
03
Conditions
lung nodule (SPN)
Beyond the preview
Go deeper on ChiCTR1900023085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023085.